MedTrace Logo

Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer

NCT06252233 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2024-12-16

No results posted yet for this study

Summary

The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.

Conditions

Interventions

BEHAVIORAL

patient- and physician-centered QoL monitoring

Electronic QoL monitoring including QoL diagnosis and therapy (pain therapy, psychotherapy, social support, nutrition, physiotherapy, fitness, respiratory counselling, palliative care). Patients and treating physicians have access to the results of their QoL monitoring and to a network of local healthcare providers.

OTHER

Placebo

Electronic QoL monitoring without QoL diagnosis and therapy. Patients and treating physicians have no access to the results of their QoL monitoring. The therapist network is also available for control arm.

Sponsors & Collaborators

  • University of Regensburg, Tumor Center Regensburg, Center for Quality Management and Health Services Research

    collaborator UNKNOWN

  • G-BA Innovationsfonds

    collaborator UNKNOWN

  • University Hospital Regensburg, Center for Clinical Trials

    collaborator UNKNOWN

  • Bavarian Cancer Registry, Bavarian Health and Food Safety Authority

    collaborator UNKNOWN

  • University of Bayreuth

    lead OTHER

Principal Investigators

  • Martin Emmert, PhD, Prof. · University of Bayreuth, Faculty of Law, Business and Economics, Institute for Healthcare Management and Health Sciences

  • Monika Klinkhammer-Schalke, MD, Prof. · University of Regensburg, Centre for Quality Management and Health Services Resarch

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-15
Primary Completion
2025-02-15
Completion
2025-08-15

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06252233 on ClinicalTrials.gov